How Drug Promotion Might Change Under Trump's Rx Pricing Plan
Executive Summary
DTC disclosure requirements are shiny but probably not substantive; copay navigator might be weightier.
You may also be interested in...
Industry Makes A Drug Price Transparency Push In DTC Ads, But Is It Too Little Too Late?
PhRMA unveiled a voluntary policy under which drug makers will provide information in DTC ads about how to access drug prices and cost information. But hours later HHS issued a proposed rule on the same topic, only requiring drug makers to include WAC prices in TV ads. .
Trump's Drug Pricing Blueprint: An Administrative Vs. Legislative Breakdown
Where can HHS go it alone, and where does it need Congress?
'Immediate' Steps To Lower Drug Prices: The HHS Action Plan
Many of blueprint's proposals could be accomplished administratively, but will still be shaped by stakeholder feedback.